Akoya BioSciences Inc.

7.88+0.1900+2.47%Vol 91.35K1Y Perf -32.43%
Mar 24th, 2023 16:00 DELAYED
BID7.50 ASK12.51
Open7.57 Previous Close7.69
Pre-Market- After-Market7.88
 - -  - -%
Target Price
18.00 
Analyst Rating
Strong Buy 1.07
Potential %
128.43 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-100/-100/43 
Value Ranking
     40.49
Insiders Value % 3/6/12 mo.
-100/-100/41 
Growth Ranking
     36.46
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/39 
Income Ranking
 —    -
Price Range Ratio 52W %
7.26 
Earnings Rating
Market Cap302.13M 
Earnings Date
4th May 2023
Alpha-0.03 Standard Deviation0.13
Beta0.64 

Today's Price Range

7.537.90

52W Range

7.2016.57

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-1.99%
1 Month
-35.41%
3 Months
-22.36%
6 Months
-27.77%
1 Year
-32.43%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
AKYA7.880.19002.47
AAPL160.251.32000.83
GOOG106.08-0.1850-0.17
MSFT280.572.91001.05
XOM103.530.12000.12
WFC36.23-0.3800-1.04
JNJ152.651.52001.01
FB196.640.99000.51
GE91.37-0.2200-0.24
JPM124.91-1.9300-1.52
 
ProfitabilityValueIndustryS&P 500US Markets
59.60
-94.40
-84.90
-
-96.51
RevenueValueIndustryS&P 500US Markets
53.64M
1.41
-
-
Earnings HistoryEstimateReportedSurprise %
Q04 2022-0.41-0.50-21.95
Q03 2022-0.40-0.47-17.50
Q02 2022-0.34-0.47-38.24
Q01 2022-0.37-0.44-18.92
Q04 2021-0.31-0.47-51.61
Q03 2021-0.28-0.31-10.71
Q02 2021-0.23-0.2013.04
Q01 2021-0.15-2.85-1 800.00
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date4th May 2023
Estimated EPS Next Report-0.46
Estimates Count4
EPS Growth Next 5 Years %-
Volume Overview
Volume91.35K
Shares Outstanding38.34K
Shares Float19.93M
Trades Count1.67K
Dollar Volume709.10K
Avg. Volume175.35K
Avg. Weekly Volume264.31K
Avg. Monthly Volume144.11K
Avg. Quarterly Volume117.62K

Akoya BioSciences Inc. (NASDAQ: AKYA) stock closed at 7.88 per share at the end of the most recent trading day (a 2.47% change compared to the prior day closing price) with a volume of 91.35K shares and market capitalization of 302.13M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 169 people. Akoya BioSciences Inc. CEO is Brian McKelligon.

The one-year performance of Akoya BioSciences Inc. stock is -32.43%, while year-to-date (YTD) performance is -17.66%. AKYA stock has a five-year performance of %. Its 52-week range is between 7.2 and 16.57, which gives AKYA stock a 52-week price range ratio of 7.26%

Akoya BioSciences Inc. currently has a PE ratio of -5.30, a price-to-book (PB) ratio of 5.02, a price-to-sale (PS) ratio of 6.81, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -37.19%, a ROC of -43.08% and a ROE of -65.08%. The company’s profit margin is -96.51%, its EBITDA margin is -84.90%, and its revenue ttm is $53.64 Million , which makes it $1.41 revenue per share.

Of the last four earnings reports from Akoya BioSciences Inc., there were 0 positive earnings surprise and 4 negative earnings surprise. The company has EPS estimate of $-0.46 for the next earnings report. Akoya BioSciences Inc.’s next earnings report date is 04th May 2023.

The consensus rating of Wall Street analysts for Akoya BioSciences Inc. is Strong Buy (1.07), with a target price of $18, which is +128.43% compared to the current price. The earnings rating for Akoya BioSciences Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Akoya BioSciences Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Akoya BioSciences Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 52.41, ATR14 : 0.71, CCI20 : -91.57, Chaikin Money Flow : -0.05, MACD : -1.00, Money Flow Index : 8.08, ROC : -25.80, RSI : 29.89, STOCH (14,3) : 16.55, STOCH RSI : 0.96, UO : 41.78, Williams %R : -83.46), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Akoya BioSciences Inc. in the last 12-months were: Brian McKelligon (Option Excercise at a value of $10 605), Brian McKelligon (Sold 35 000 shares of value $397 542 ), Garry Nolan (Sold 63 106 shares of value $839 235 ), Joseph Driscoll (Option Excercise at a value of $120 830), Joseph Driscoll (Sold 24 613 shares of value $308 706 ), Niro Ramachandran (Option Excercise at a value of $99 287), Thomas P. Schnettler (Sold 71 050 shares of value $925 782 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
6 (85.71 %)
6 (85.71 %)
5 (83.33 %)
Moderate Buy
1 (14.29 %)
1 (14.29 %)
1 (16.67 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.07
Strong Buy
1.07
Strong Buy
1.08

Akoya BioSciences Inc.

Akoya Biosciences Inc is an an innovative life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery and clinical research. It offers the most comprehensive, end-to-end solutions for high-parameter tissue analysis from discovery through clinical and translational research, enabling the development of more precise therapies for immuno-oncology and other drug development applications.

CEO: Brian McKelligon

Telephone: +1 855 896-8401

Address: 100 Campus Drive, 6th Floor, Marlborough 01752, MA, US

Number of employees: 169

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

55%45%

Bearish Bullish

59%41%

Bearish Bullish

59%41%


News

Stocktwits